Solventum (SOLV) to Release Quarterly Earnings on Thursday

Solventum (NYSE:SOLV) is expected to be issuing its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $1.31 per share and revenue of $2.05 billion for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Solventum Trading Up 4.5 %

Solventum stock opened at $76.30 on Tuesday. Solventum has a 52 week low of $47.16 and a 52 week high of $96.05. The stock has a 50-day moving average price of $71.28 and a 200 day moving average price of $69.37. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on SOLV. Mizuho began coverage on Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target for the company. Morgan Stanley boosted their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Finally, Piper Sandler boosted their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Solventum has an average rating of “Hold” and a consensus target price of $68.29.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.